TEKLA CAPITAL MANAGEMENT LLC – Neurocrine Biosciences, Inc. Transaction History
TEKLA CAPITAL MANAGEMENT LLC portfolio value:
$17.85M
portfolio value
TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.46M | $106.21 | 168.10K | |
| Q2 2022 | share | Increase | +34.91% | 43.49K shares | 4.70M | $97.48 | 168.10K |
| Q1 2022 | share | 0.00% | 0 shares | 1.06M | $93.75 | 124.60K | |
| Q4 2021 | share | 0.00% | 0 shares | -1.33M | $84.63 | 124.60K | |
| Q3 2021 | share | Decrease | -41.47% | -88.28K shares | -8.76M | $95.91 | 124.60K |
| Q2 2021 | share | 0.00% | 0 shares | 15K | $97.32 | 212.89K | |
| Q1 2021 | share | Decrease | -27.65% | -81.34K shares | -7.49M | $97.25 | 212.89K |
| Q4 2020 | share | Increase | +365.54% | 231.03K shares | 22.12M | $95.85 | 294.23K |
| Q3 2020 | share | Decrease | -69.34% | -142.94K shares | -19.07M | $96.16 | 63.20K |
| Q2 2020 | share | 0.00% | 0 shares | 7.30M | $122 | 206.15K | |
| Q1 2020 | share | Increase | +6.79% | 13.10K shares | -2.90M | $86.55 | 206.15K |
| Q4 2019 | share | Decrease | -6.66% | -13.78K shares | 2.11M | $107.49 | 193.04K |
| Q3 2019 | share | Decrease | -0.12% | -256 shares | 1.15M | $90.11 | 206.82K |
| Q2 2019 | share | Decrease | -6.59% | -14.6K shares | -2.04M | $84.43 | 207.07K |
| Q1 2019 | share | Increase | +2.49% | 5.38K shares | 4.08M | $88.1 | 221.67K |
| Q4 2018 | share | Increase | +1.72% | 3.66K shares | -10.69M | $71.41 | 216.29K |
| Q3 2018 | share | Decrease | -21.18% | -57.13K shares | -359K | $122.95 | 212.63K |
| Q2 2018 | share | Decrease | -3.45% | -9.65K shares | 3.33M | $98.24 | 269.76K |
| Q1 2018 | share | Decrease | -14.04% | -45.64K shares | -2.05M | $82.93 | 279.41K |
| Q4 2017 | share | Decrease | -42.21% | -237.4K shares | -9.24M | $77.59 | 325.06K |
| Q3 2017 | share | 0.00% | 0 shares | 8.59M | $61.28 | 562.46K | |
| Q2 2017 | share | Increase | +26.09% | 116.39K shares | 6.55M | $46 | 562.46K |
| Q1 2017 | share | Increase | +13.83% | 54.20K shares | 4.15M | $43.3 | 446.07K |
| Q4 2016 | share | Decrease | -40.32% | -264.75K shares | -18.08M | $38.7 | 391.86K |
| Q3 2016 | share | Decrease | -14.39% | -110.4K shares | -1.61M | $50.64 | 656.62K |
| Q3 2016 | call | Decrease | -100.00% | -110.4K shares | -5.01M | $50.64 | 0 |
| Q2 2016 | call | Increase | 0.00% | 110.4K shares | 5.01M | $45.45 | 110.4K |
| Q2 2016 | share | Increase | +146.27% | 455.56K shares | 22.54M | $45.45 | 767.02K |
| Q1 2016 | share | 0.00% | 0 shares | -5.30M | $39.55 | 311.46K |